Response Genetics Inc
Response Genetics, Inc., a life sciences company, researches, develops, markets, and sells pharmacogenomic tests for use in the treatment of cancer in the United States, Europe, and internationally. The company offers tests for measuring predictive factors for therapy response in tumor tissue samples. It provides testing services for non-small cell lung cancer, colorectal cancer, gastric and gast… Read more
Response Genetics Inc (RGDXQ) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of March 2015: 0.381x
Based on the latest financial reports, Response Genetics Inc (RGDXQ) has a cash flow conversion efficiency ratio of 0.381x as of March 2015.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.88 Million) by net assets ($-4.94 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Response Genetics Inc - Cash Flow Conversion Efficiency Trend (2005–2015)
This chart illustrates how Response Genetics Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Response Genetics Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Response Genetics Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ZipLink Inc
PINK:ZIPL
|
-0.432x |
|
Fitvia Corp
PINK:BRZV
|
0.000x |
|
Universal Tracking Solutions Inc
PINK:UTRK
|
-1.172x |
|
LCTI Low Carbon Technologies International Inc
PINK:LWCTF
|
-0.004x |
|
Idglobal Corp
PINK:IDGC
|
-0.005x |
|
Foodfest Intl 2000
PINK:FDFT
|
-0.051x |
|
Buzz Technologies Inc
PINK:BZTG
|
-0.157x |
|
International Card Establishment Inc
PINK:ICRD
|
1.320x |
Annual Cash Flow Conversion Efficiency for Response Genetics Inc (2005–2015)
The table below shows the annual cash flow conversion efficiency of Response Genetics Inc from 2005 to 2015.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2015-12-31 | $33.02 Million | $-13.60 Million | -0.412x | -103.37% |
| 2014-12-31 | $-1.17 Million | $-14.30 Million | 12.221x | +1184.66% |
| 2013-12-31 | $5.76 Million | $-6.49 Million | -1.127x | -107.63% |
| 2012-12-31 | $-542.21K | $-8.01 Million | 14.775x | +1683.69% |
| 2011-12-31 | $-6.14 Million | $-5.08 Million | 0.828x | -58.21% |
| 2010-12-31 | $-3.28 Million | $-6.49 Million | 1.982x | +115.29% |
| 2009-12-31 | $649.22K | $-8.41 Million | -12.961x | -1211.40% |
| 2008-12-31 | $6.87 Million | $-6.79 Million | -0.988x | -328.26% |
| 2007-12-31 | $15.11 Million | $-3.49 Million | -0.231x | +60.03% |
| 2006-12-31 | $-5.50 Million | $3.18 Million | -0.577x | -195.26% |
| 2005-12-31 | $-3.19 Million | $624.52K | -0.196x | -- |